A target for tumour-directed therapy

This publication has 9 references indexed in Scilit:

• Prevention of breast tumour development in vivo by downregulation of the p185neureceptor
  Nature Medicine, 1995
• Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth
  British Journal of Cancer, 1993
• An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice
  The Journal of cell biology, 1993
• Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
  Proceedings of the National Academy of Sciences, 1992
• Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung Carcinoma
  JNCI Journal of the National Cancer Institute, 1991
• Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
  Cell, 1989
• p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
  Molecular and Cellular Biology, 1989
• Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen.
  Proceedings of the National Academy of Sciences, 1986
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985